This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harokopakis, E.
Right arrow Articles by Michalek, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harokopakis, E.
Right arrow Articles by Michalek, S. M.

 Previous Article  |  Next Article 

Infection and Immunity, September 1998, p. 4299-4304, Vol. 66, No. 9
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Effectiveness of Liposomes Possessing Surface-Linked Recombinant B Subunit of Cholera Toxin as an Oral Antigen Delivery System

Evlambia Harokopakis, George Hajishengallis, and Suzanne M. Michalek*

Departments of Microbiology and Oral Biology, University of Alabama at Birmingham, Birmingham, Alabama 35294

Received 22 December 1997/Returned for modification 7 April 1998/Accepted 23 June 1998

Liposomes appear to be a promising oral antigen delivery system for the development of vaccines against infectious diseases, although their uptake efficiency by Peyer's patches in the gut and the subsequent induction of mucosal immunoglobulin A (IgA) responses remain a major concern. Aiming at targeted delivery of liposomal immunogens, we have previously reported the conjugation via a thioether bond of the GM1 ganglioside-binding subunit of cholera toxin (CTB) to the liposomal outer surface. In the present study, we have investigated the effectiveness of liposomes containing the saliva-binding region (SBR) of Streptococcus mutans AgI/II adhesin and possessing surface-linked recombinant CTB (rCTB) in generating mucosal (salivary, vaginal, and intestinal) IgA as well as serum IgG responses to the parent molecule, AgI/II. Responses in mice given a single oral dose of the rCTB-conjugated liposomes were compared to those in mice given one of the following unconjugated liposome preparations: (i) empty liposomes, (ii) liposomes containing SBR, (iii) liposomes containing SBR and coadministered with rCTB, and (iv) liposomes containing SBR plus rCTB. Three weeks after the primary immunization, significantly higher levels of mucosal IgA and serum IgG antibodies to AgI/II were observed in the rCTB-conjugated group than in mice given the unconjugated liposome preparations, although the latter mice received a booster dose at week 9. The antibody responses in mice immunized with rCTB-conjugated liposomes persisted at high levels for at least 6 months, at which time (week 26) a recall immunization significantly augmented the responses. In general, mice given unconjugated liposome preparations required one or two booster immunizations to develop a substantial anti-AgI/II antibody response, which was more prominent in the group given coencapsulated SBR and rCTB. These data indicate that conjugation of rCTB to liposomes greatly enhances their effectiveness as an antigen delivery system. This oral immunization strategy should be applicable for the development of vaccines against oral, intestinal, or sexually transmitted diseases.


* Corresponding author. Mailing address: The University of Alabama at Birmingham, Department of Microbiology, 845 19th St. South, BBRB 258/5, Birmingham, AL 35294-2170. Phone: (205) 934-3470. Fax: (205) 934-1426. E-mail: sue_michalek{at}micro.microbio.uab.edu.


Infection and Immunity, September 1998, p. 4299-4304, Vol. 66, No. 9
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Krishnan, L., Sad, S., Patel, G. B., Sprott, G. D. (2003). Archaeosomes Induce Enhanced Cytotoxic T Lymphocyte Responses to Entrapped Soluble Protein in the Absence of Interleukin 12 and Protect against Tumor Challenge. Cancer Res. 63: 2526-2534 [Abstract] [Full Text]  
  • Martin, M., Sharpe, A., Clements, J. D., Michalek, S. M. (2002). Role of B7 Costimulatory Molecules in the Adjuvant Activity of the Heat-Labile Enterotoxin of Escherichiacoli. J. Immunol. 169: 1744-1752 [Abstract] [Full Text]  
  • Barackman, J. D., Ott, G., Pine, S., O'Hagan, D. T. (2001). Oral Administration of Influenza Vaccine in Combination with the Adjuvants LT-K63 and LT-R72 Induces Potent Immune Responses Comparable to or Stronger than Traditional Intramuscular Immunization. CVI 8: 652-657 [Abstract] [Full Text]  
  • Krishnan, L., Sad, S., Patel, G. B., Sprott, G. D. (2001). The Potent Adjuvant Activity of Archaeosomes Correlates to the Recruitment and Activation of Macrophages and Dendritic Cells In Vivo. J. Immunol. 166: 1885-1893 [Abstract] [Full Text]  
  • Martin, M., Hajishengallis, G., Metzger, D. J., Michalek, S. M., Connell, T. D., Russell, M. W. (2001). Recombinant Antigen-Enterotoxin A2/B Chimeric Mucosal Immunogens Differentially Enhance Antibody Responses and B7-Dependent Costimulation of CD4+ T Cells. Infect. Immun. 69: 252-261 [Abstract] [Full Text]  
  • Krishnan, L., Sad, S., Patel, G. B., Sprott, G. D. (2000). Archaeosomes Induce Long-Term CD8+ Cytotoxic T Cell Response to Entrapped Soluble Protein by the Exogenous Cytosolic Pathway, in the Absence of CD4+ T Cell Help. J. Immunol. 165: 5177-5185 [Abstract] [Full Text]  
  • Brady, L. J., van Tilburg, M. L. J. A., Alford, C. E., McArthur, W. P. (2000). Monoclonal Antibody-Mediated Modulation of the Humoral Immune Response against Mucosally Applied Streptococcus mutans. Infect. Immun. 68: 1796-1805 [Abstract] [Full Text]  
  • Krishnan, L., Dicaire, C. J., Patel, G. B., Sprott, G. D. (2000). Archaeosome Vaccine Adjuvants Induce Strong Humoral, Cell-Mediated, and Memory Responses: Comparison to Conventional Liposomes and Alum. Infect. Immun. 68: 54-63 [Abstract] [Full Text]